- Preclinical study showed weight and fat reduction without significant lean mass loss relative to vehicle controls.
- Limited weight regain observed post-treatment compared to semaglutide in mouse model.
- Candidate remains at early preclinical stage; clinical safety and efficacy unproven.
?? Positive AI Sentiment (+3.0 / 10)